{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:05:51Z","timestamp":1789387551304,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81000509"],"award-info":[{"award-number":["81000509"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jpsychires.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T17:32:47Z","timestamp":1623259967000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-na\u00efve patients with schizophrenia"],"prefix":"10.1016","volume":"140","author":[{"given":"Jia Hong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Ni","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Hong","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jpsychires.2021.06.001_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","article-title":"Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?","volume":"29","author":"Aichhorn","year":"2006","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.06.001_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal","volume":"22","author":"Alvarez-Jimenez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2021.06.001_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2018.06.012","article-title":"Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences","volume":"192","author":"Aringhieri","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41371-019-0248-1","article-title":"Effects of L-carnitine supplementation on blood pressure: a systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Askarpour","year":"2019","journal-title":"J. Hum. Hypertens."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.06.001_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094112","article-title":"Almost all antipsychotics result in weight gain: a meta-analysis","volume":"9","author":"Bak","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.06.001_bib6","doi-asserted-by":"crossref","first-page":"e749","DOI":"10.4088\/JCP.11m07246","article-title":"Weight change from 3-year observational data: findings from the worldwide schizophrenia outpatient health outcomes database","volume":"73","author":"Bushe","year":"2012","journal-title":"J. Clin. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.06.001_bib7","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naive schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep37674","article-title":"Effects of MeJA on Arabidopsis metabolome under endogenous JA deficiency","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.06.001_bib9","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/acs.jproteome.6b01062","article-title":"Blood metabolic signatures of body mass index: a targeted metabolomics study in the EPIC cohort","volume":"16","author":"Carayol","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fnins.2016.00488","article-title":"From molecules to the clinic: linking schizophrenia and metabolic syndrome through sphingolipids metabolism","volume":"10","author":"Castillo","year":"2016","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.06.001_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/011542650802300116","article-title":"Obesity, inflammation, and the potential application of pharmaconutrition","volume":"23","author":"Cave","year":"2008","journal-title":"Nutr. Clin. Pract."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.06.001_bib12","first-page":"104","article-title":"Efficacy and metabolic influence on blood-glucose and serum lipid of ziprasidone in the treatment of elderly patients with first-episode schizophrenia","volume":"29","author":"Chen","year":"2017","journal-title":"Shanghai Arch Psychiatry"},{"key":"10.1016\/j.jpsychires.2021.06.001_bib13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2020.00902","article-title":"Metabolomic analysis of the effects of adipose-derived mesenchymal stem cell treatment on rats with sepsis-induced acute lung injury","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-7075-7-30","article-title":"Role of carnitine in disease","volume":"7","author":"Flanagan","year":"2010","journal-title":"Nutr. Metab."},{"issue":"11","key":"10.1016\/j.jpsychires.2021.06.001_bib15","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ijo.2014.39","article-title":"Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study","volume":"38","author":"Floegel","year":"2014","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.06.001_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cll.2010.07.010","article-title":"Pharmacogenetics and schizophrenia","volume":"30","author":"Foster","year":"2010","journal-title":"Clin. Lab. Med."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib17","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.4049\/jimmunol.178.10.6540","article-title":"Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A","volume":"178","author":"Frasch","year":"2007","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jpsychires.2021.06.001_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111336","article-title":"Second-Generation antipsychotics and dysregulation of glucose metabolism: beyond weight gain","volume":"8","author":"Grajales","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jpsychires.2021.06.001_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2014.38","article-title":"Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults","volume":"4","author":"Hanamatsu","year":"2014","journal-title":"Nutr. Diabetes"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.06.001_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.psyneuen.2012.09.009","article-title":"Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies","volume":"38","author":"Harris","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2021.06.001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.76","article-title":"Schizophrenia shows a unique metabolomics signature in plasma","volume":"2","author":"He","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2021.06.001_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030327","article-title":"Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia","volume":"3","author":"Holmes","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108393","article-title":"Molecular phenomics of a high-calorie diet-induced porcine model of prepubertal obesity","volume":"83","author":"Jov\u00e9","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.06.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030363","article-title":"Metabolic profiling of patients with schizophrenia","volume":"3","author":"Kaddurah-Daouk","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.06.001_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","article-title":"Impaired plasmalogens in patients with schizophrenia","volume":"198","author":"Kaddurah-Daouk","year":"2012","journal-title":"Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatr."},{"issue":"9618","key":"10.1016\/j.jpsychires.2021.06.001_bib27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jpsychires.2021.06.001_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2217\/pgs.13.207","article-title":"Genetics of antipsychotic-induced weight gain: update and current perspectives","volume":"14","author":"Kao","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.jpsychires.2021.06.001_bib29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2174\/1570159X17666190228113348","article-title":"Association between serum lipids and antipsychotic response in schizophrenia","volume":"17","author":"Kim","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.06.001_bib30","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1021\/pr100101p","article-title":"Metabolic profiling of plasma in overweight\/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS)","volume":"9","author":"Kim","year":"2010","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.06.001_bib31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.jcp.0000161501.65890.22","article-title":"Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders","volume":"25","author":"Kinon","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.06.001_bib32","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"Pt A","key":"10.1016\/j.jpsychires.2021.06.001_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2018.01.020","article-title":"Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia","volume":"84","author":"Lin","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2021.06.001_bib34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","article-title":"Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain","volume":"69","author":"Malhotra","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.06.001_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12445","article-title":"Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management","volume":"132","author":"Manu","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.06.001_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics","volume":"8","author":"McEvoy","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.06.001_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.06.001_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4088\/JCP.v63n0509","article-title":"A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year","volume":"63","author":"Meyer","year":"2002","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.06.001_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740338.2015.974549","article-title":"Weight gain and antipsychotics: a drug safety review","volume":"14","author":"Musil","year":"2015","journal-title":"Expet Opin. Drug Saf."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2021.06.001_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00114-2","article-title":"A review of the effect of atypical antipsychotics on weight","volume":"28","author":"Nasrallah","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib41","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1021\/pr2005555","article-title":"Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes","volume":"10","author":"Oberbach","year":"2011","journal-title":"J. Proteome Res."},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2021.06.001_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2008.09.028","article-title":"Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naive population","volume":"107","author":"Perez-Iglesias","year":"2009","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165853","article-title":"Implication of phosphatidylethanolamine N-methyltransferase in adipocyte differentiation","volume":"1866","author":"Presa","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2016.02.031","article-title":"Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients","volume":"617","author":"Qiao","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.06.001_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11306-013-0590-1","article-title":"Changes in metabolite profiles caused by genetically determined obesity in mice","volume":"10","author":"Schafer","year":"2014","journal-title":"Metabolomics"},{"issue":"10","key":"10.1016\/j.jpsychires.2021.06.001_bib46","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/pr800188y","article-title":"High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides","volume":"7","author":"Schwarz","year":"2008","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2021.06.001_bib47","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1176\/ajp.156.9.1471-a","article-title":"Olanzapine-induced elevation of plasma triglyceride levels","volume":"156","author":"Sheitman","year":"1999","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.06.001_bib48","first-page":"145","article-title":"Leptin -2548g\/a gene polymorphism in association with antipsychotic-induced weight gain: a meta-analysis study","volume":"26","author":"Shen","year":"2014","journal-title":"Psychiatr. Danub."},{"issue":"7 Suppl. l","key":"10.1016\/j.jpsychires.2021.06.001_bib49","first-page":"S3","article-title":"Pathophysiology, epidemiology, and assessment of obesity in adults","volume":"63","author":"Skolnik","year":"2014","journal-title":"J. Fam. Pract."},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2021.06.001_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2007.02.024","article-title":"Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis","volume":"93","author":"Strassnig","year":"2007","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.06.001_bib51","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/omi.2012.0062","article-title":"Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: towards metabolomics diagnostics","volume":"16","author":"Szymanska","year":"2012","journal-title":"OMICS"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.06.001_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0033291709990407","article-title":"Weight gain in antipsychotic-naive patients: a review and meta-analysis","volume":"40","author":"Tarricone","year":"2010","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.06.001_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/pr0503782","article-title":"Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.06.001_bib54","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1194\/jlr.M013854","article-title":"Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids","volume":"52","author":"Vladykovskaya","year":"2011","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.06.001_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pscychresns.2013.06.011","article-title":"Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study","volume":"214","author":"Weber-Fahr","year":"2013","journal-title":"Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.jpsychires.2021.06.001_bib56","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/pr2006796","article-title":"Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action","volume":"10","author":"Xuan","year":"2011","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.06.001_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109952","article-title":"Association between the -2548G\/A polymorphism of the leptin gene and antipsychotic-induced weight gain: analysis of the CATIE sample and meta-analysis","volume":"102","author":"Yoshida","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.06.001_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75624-2","article-title":"Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain","volume":"10","author":"Zapata","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jpsychires.2021.06.001_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22218","article-title":"Improvement of insulin resistance via increase of GLUT4 and PPAR\u03b3 in metabolic syndrome-induced rats treated with omega-3 fatty acid or l-carnitine","volume":"32","author":"Zayed","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.06.001_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/obr.12011","article-title":"Power of metabolomics in biomarker discovery and mining mechanisms of obesity","volume":"14","author":"Zhang","year":"2013","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jpsychires.2021.06.001_bib62","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.psyneuen.2017.04.014","article-title":"Metabolic adverse effects of olanzapine on cognitive dysfunction: a possible relationship between BDNF and TNF-alpha","volume":"81","author":"Zhang","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpsychires.2021.06.001_bib63","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","article-title":"Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.06.001_bib64","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12785","article-title":"Metabolic effects of 7 antipsychotics on patients with schizophrenia: a short-term, randomized, open-label, multicenter, pharmacologic trial","volume":"81","author":"Zhang","year":"2020","journal-title":"J. Clin. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:24:10Z","timestamp":1758367450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621003757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":64,"alternative-id":["S0022395621003757"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.06.001","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-na\u00efve patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}